Skip to content
Tuesday, November 17, 2026 · Today’s edition, 6:30 a.m. ETTue, Nov 17 · 6:30 a.m. editionSign inMy Desk 0EditionsSign in

Who holds VRDNVIRIDIAN THERAPEUTICS

13 funds on our shelf carry VIRIDIAN THERAPEUTICS — heaviest hand: SBIO at 2.30% of its book.

FundWeightFund assetsShares held
SBIOALPS Medical Breakthroughs ETFACTIVE2.30%$114M138,693
BBCVirtus Biotech Clinical Trials ETF1.45%—15,307
XBIState Street SPDR S&P Biotech ETFINDEX0.78%$10.3B2,575,141
IWCiShares Micro-Cap ETFINDEX0.77%$1.3B304,679
FYCFirst Trust Small Cap Growth AlphaDEX Fund0.57%$319M253,862
TMSLT. Rowe Price Small-Mid Cap ETFACTIVE0.21%$192M228,147
IWNiShares Russell 2000 Value ETFINDEX0.18%$13.9B847,090
LABUDirexion Daily S&P Biotech Bull 3X ETFINDEX0.16%$624M95,660
FFSMFidelity Fundamental Small-Mid Cap ETFINDEX0.15%$86M71,866
PWSPacer WealthShield ETFACTIVE0.15%$20M790
VTWVVanguard Russell 2000 Value ETFINDEX0.15%$813M81,763
FHLCFidelity MSCI Health Care Index ETFINDEX0.03%$3.2B40,473
VHTVanguard Health Care Index FundINDEX0.03%$19B236,726

LATEST DISCLOSED BOOKS ON THE ENRICHED SHELF · THE SHELF GROWS NIGHTLY AS READERS RESEARCH NEW FUNDS

ETF Dailyfrom Private Wealth Daily

ETF launches, fund research, and market coverage in your inbox every morning. Free.

Free. Every morning. Unsubscribe from any edition in one click.